tiprankstipranks
Trending News
More News >

Christi Shaw Insider Profile

4 Followers
Christi Shaw, SVP and Pres., Lilly Bio-Meds at Eli Lilly & Co, holds 16.63K shares in Kyverna Therapeutics, Inc. (Ticker: KYTX), holds 36.27K shares in Avantor (Ticker: AVTR), holds 0.00 shares in Eli Lilly & Co (Ticker: LLY).
tipranks
Christi Shaw

Christi Shaw
Eli Lilly & Co (LLY)
SVP and Pres., Lilly Bio-Meds

Ranked #83,614 out of 105,219 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-42.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$518K
77.52%
22.48%
0.00%
0.00%
A breakdown of Christi Shaw's holdings

Insider Roles

Avantor
(AVTR)
Director
Kyverna Therapeutics, Inc.
(KYTX)
Director
Eli Lilly & Co
(LLY)
SVP and Pres., Lilly Bio-Meds
Beam Therapeutics
(BEAM)
Director
Roles that Christi Shaw holds in companies

Most Profitable Insider Trade

Stock:
Eli Lilly & Co
(LLY)
Rating:Informative Sell
Date:May 31, 2018 - May 31, 2019
Return:-39.30%
The most profitable trade made by Christi Shaw

Christi Shaw's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eli Lilly & Co
May 07, 2019
SVP and Pres., Lilly Bio-Meds
Uninformative Sell
887.57K
$0.00
Avantor
May 15, 2023
Director
Uninformative Buy
$401.52K
Beam Therapeutics
Director
Kyverna Therapeutics, Inc.
Jun 02, 2025
Director
Uninformative Buy
$116.44K
List of latest transactions for each holding click on a transaction to see Christi Shaw's performance on stock

Christi Shaw insider profile FAQ

What is the percentage of profitable transactions made by Christi Shaw?
The percentage of profitable transactions made by Christi Shaw is 0%.
    What is the average return per transaction made by Christi Shaw?
    The average return per transaction made by Christi Shaw is -42.00%.
      What stocks does Christi Shaw hold?
      Christi Shaw holds: LLY, AVTR, BEAM, KYTX stocks.
        What was Christi Shaw’s latest transaction?
        Christi Shaw latest transaction was an Uninformative Buy of ―.
          What was Christi Shaw's most profitable transaction?
          Christi Shaw’s most profitable transaction was an Informative Sell of LLY stock on May 31, 2018. The return on the trade was -39.30%.
            What is Christi Shaw's role in Eli Lilly & Co?
            Christi Shaw's role in Eli Lilly & Co is SVP and Pres., Lilly Bio-Meds.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.